Golimumab - Latest Advances

Multifocal cutaneous leishmaniasis in a patient treated with golimumab for psoriaticarthritis.

Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists

Published: September 22, 2025

TNF-α inhibitor therapy and prosthetic aortic valve endocarditis: a case report.

Journal: Future cardiology

Published: September 01, 2025

Refractory oral manifestations of Crohn's disease.

Journal: Journal of stomatology, oral and maxillofacial surgery

Published: August 27, 2025

The Efficacy and Safety of Tumor Necrosis Factor alpha Inhibitors in the Treatment of Noninfectious Uveitis: A Systematic Review and Meta-Analysis.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: August 05, 2025

Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.

Journal: The Journal of rheumatology

Published: August 05, 2025

Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.

Journal: The Journal of rheumatology

Published: August 05, 2025

Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study.

Journal: Journal of clinical medicine

Published: August 03, 2025

Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Journal: Current medical research and opinion

Published: July 18, 2025

Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Journal: Current medical research and opinion

Published: July 18, 2025

Generalized Pustular Psoriasis as a Systemic Inflammatory Disease: Experience With 38 Japanese Cases Over 15 Years at a Single Institution.

Journal: Cureus

Published: July 15, 2025

Corneal Adverse Events Temporally Associated with Anti-TNF-α Therapy: Severe Fibrovascular Pannus and a Non-Pannus Epitheliopathy in Two Cases.

Journal: International medical case reports journal

Published: June 19, 2025

Influence of Pharmacokinetic-Pharmacodynamic Failure Mechanisms on Outcomes in Biologic Therapy Sequencing in Inflammatory Bowel Disease: A Retrospective Cohort Study.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: May 29, 2025

Filters

Multifocal cutaneous leishmaniasis in a patient treated with golimumab for psoriaticarthritis.

Multifocal cutaneous leishmaniasis in a patient treated with golimumab for psoriaticarthritis.

TNF-α inhibitor therapy and prosthetic aortic valve endocarditis: a case report.

TNF-α inhibitor therapy and prosthetic aortic valve endocarditis: a case report.

Refractory oral manifestations of Crohn's disease.

Refractory oral manifestations of Crohn's disease.

The Efficacy and Safety of Tumor Necrosis Factor alpha Inhibitors in the Treatment of Noninfectious Uveitis: A Systematic Review and Meta-Analysis.

The Efficacy and Safety of Tumor Necrosis Factor alpha Inhibitors in the Treatment of Noninfectious Uveitis: A Systematic Review and Meta-Analysis.

Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.

Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.

Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.

Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.

Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study.

Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study.

Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Generalized Pustular Psoriasis as a Systemic Inflammatory Disease: Experience With 38 Japanese Cases Over 15 Years at a Single Institution.

Generalized Pustular Psoriasis as a Systemic Inflammatory Disease: Experience With 38 Japanese Cases Over 15 Years at a Single Institution.

Corneal Adverse Events Temporally Associated with Anti-TNF-α Therapy: Severe Fibrovascular Pannus and a Non-Pannus Epitheliopathy in Two Cases.

Corneal Adverse Events Temporally Associated with Anti-TNF-α Therapy: Severe Fibrovascular Pannus and a Non-Pannus Epitheliopathy in Two Cases.

Influence of Pharmacokinetic-Pharmacodynamic Failure Mechanisms on Outcomes in Biologic Therapy Sequencing in Inflammatory Bowel Disease: A Retrospective Cohort Study.

Influence of Pharmacokinetic-Pharmacodynamic Failure Mechanisms on Outcomes in Biologic Therapy Sequencing in Inflammatory Bowel Disease: A Retrospective Cohort Study.